NCT00443612View on ClinicalTrials.gov

Irbesartan/Hydrochlorothiazide National Taiwan University Hospital Listing

PHASE4CompletedINTERVENTIONAL

Enrollment

60

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

October 31, 2008

Conditions

Hypertension

Interventions

DRUG

Irbesartan/Hydrochlorothiazide

Administration of irbesartan 150 mg/day + hydrochlorothiazide 12.5 mg

DRUG

Irbesartan

Administration of irbesartan 150 mg/day

Trial Locations (1)

Unknown

Sanofi-Aventis, Taipei

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Sanofi

INDUSTRY